|
Asmuth, David M; Busch, Michael P; Laycock, Megan E et al. (2004) Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection. Antiviral Res 63:123-31
|
|
Asmuth, David M; Kalish, Leslie A; Laycock, Megan E et al. (2003) Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion 43:451-8
|
|
Murphy, Edward L; Grant, Robert M; Kropp, Jerry et al. (2003) Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr 33:655-6
|
|
Roback, John D; Drew, W Lawrence; Laycock, Megan E et al. (2003) CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion 43:314-21
|
|
Lee, Tzong-Hae; Wen, Li; Chrebtow, Vera et al. (2002) Quantitation of residual WBCs in filtered blood components by high-throughput, real-time kinetic PCR. Transfusion 42:87-93
|
|
Roback, J D; Hillyer, C D; Drew, W L et al. (2001) Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion 41:1249-57
|
|
Eisenbud, R; Assmann, S F; Kalish, L A et al. (2001) Differences in difficulty adjudicating clinical events in patients with advanced HIV disease. J Acquir Immune Defic Syndr 28:43-6
|
|
Kruskall, M S; Lee, T H; Assmann, S F et al. (2001) Survival of transfused donor white blood cells in HIV-infected recipients. Blood 98:272-9
|
|
Yomtovian, R; Gernsheimer, T; Assmann, S F et al. (2001) WBC reduction in RBC concentrates by prestorage filtration: multicenter experience. Transfusion 41:1030-6
|
|
Collier, A C; Kalish, L A; Busch, M P et al. (2001) Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA 285:1592-601
|
Showing the most recent 10 out of 14 publications
